Research / ARDX / Fundamental state Inspectable configuration
State dimensions Filing 0001437402-26-000013 General Corporate
Debt relative to revenue 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
49.80% · OPTIONAL · VALID
Capex intensity 60th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.37% · OPTIONAL · VALID
Operating cash generation 90th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-10.43% · OPTIONAL · VALID
Revenue growth 20th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
22.09% · CORE · VALID
Inventory pressure 7th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
30.22% · OPTIONAL · VALID
Operating margin 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
-10.06% · CORE · VALID
R&D intensity 30th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
17.56% · OPTIONAL · VALID
SBC intensity 30th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
12.02% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 32 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Mar 31, 2022 7/8 normalized Level 3 Jun 30, 2022 7/8 normalized Level 3 Sep 30, 2022 7/8 normalized Level 3 Dec 31, 2022 7/8 normalized Level 3 Mar 31, 2023 7/8 normalized Level 3 Jun 30, 2023 7/8 normalized Level 3 Sep 30, 2023 7/8 normalized Level 3 Dec 31, 2023 7/8 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 183.21%
Current 49.80%
Delta -133.42% Capex Intensity Increased
Previous 0.14%
Current 0.37%
Delta 0.22% Cash Generation Decreased
Previous 0.33%
Current -10.43%
Delta -10.76% Growth Increased
Previous 12.30%
Current 22.09%
Delta 9.79% Inventory Pressure Decreased
Previous 117.25%
Current 30.22%
Delta -87.02% Profitability Decreased
Previous 4.23%
Current -10.06%
Delta -14.29% R And D Intensity Increased
Previous 16.38%
Current 17.56%
Delta 1.18% Sbc Intensity Increased
Previous 11.55%
Current 12.02%
Delta 0.47% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.